These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. What Have We Learned from Studies of IFN-λ Variants and Hepatitis C Virus Infection? O'Brien TR; Jackson SS J Interferon Cytokine Res; 2019 Oct; 39(10):618-626. PubMed ID: 31161939 [TBL] [Abstract][Full Text] [Related]
10. IFNL4 rs368234815 and rs117648444 variants predict off-treatment HBsAg seroclearance in IFN-treated HBeAg-negative chronic hepatitis B patients. Galmozzi E; Facchetti F; Grossi G; Loglio A; Viganò M; Lunghi G; Colombo M; Lampertico P Liver Int; 2018 Mar; 38(3):417-423. PubMed ID: 28732143 [TBL] [Abstract][Full Text] [Related]
11. Lymphocytes degranulation in liver in hepatitis C virus carriers is associated with IFNL4 polymorphisms and ALT levels. Jouvin-Marche E; Macek Jílková Z; Thelu MA; Marche H; Fugier E; Van Campenhout N; Hoang XS; Marlu A; Sturm N; Callanan M; Leroy V; Zarski JP; Marche PN J Infect Dis; 2014 Jun; 209(12):1907-15. PubMed ID: 24415789 [TBL] [Abstract][Full Text] [Related]
12. Hepatic Huschka H; Mihm S Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360569 [TBL] [Abstract][Full Text] [Related]
13. Differential expression of interferon alpha inducible genes in peripheral blood mononuclear cells from patients chronically infected with hepatitis C virus and healthy donors. MacParland SA; Corkum CP; Burgess C; Karwowska S; Kroll W; Michalak TI Int Immunopharmacol; 2015 Apr; 25(2):545-52. PubMed ID: 25765354 [TBL] [Abstract][Full Text] [Related]
16. Interferon Stimulated Gene Expression in HIV/HCV Coinfected Patients Treated with Nitazoxanide/Peginterferon-Alfa-2a and Ribavirin. Petersen T; Lee YJ; Osinusi A; Amorosa VK; Wang C; Kang M; Matining R; Zhang X; Dou D; Umbleja T; Kottilil S; Peters MG AIDS Res Hum Retroviruses; 2016 Jul; 32(7):660-7. PubMed ID: 26974581 [TBL] [Abstract][Full Text] [Related]
17. Interferon-λ4 is a cell-autonomous type III interferon associated with pre-treatment hepatitis C virus burden. Lu YF; Goldstein DB; Urban TJ; Bradrick SS Virology; 2015 Feb; 476():334-340. PubMed ID: 25577150 [TBL] [Abstract][Full Text] [Related]
18. Pegylated interferons Lambda-1a and alfa-2a display different gene induction and cytokine and chemokine release profiles in whole blood, human hepatocytes and peripheral blood mononuclear cells. Freeman J; Baglino S; Friborg J; Kraft Z; Gray T; Hill M; McPhee F; Hillson J; Lopez-Talavera JC; Wind-Rotolo M J Viral Hepat; 2014 Jun; 21(6):e1-9. PubMed ID: 24827902 [TBL] [Abstract][Full Text] [Related]
20. Nonsynonymous variant Pro70Ser (rs117648444) in IFNL4 gene identifies carriers of the rs368234815 ΔG allele with higher HCV RNA decline during the first 4 weeks of pegylated interferon and ribavirin therapy in HCV-1 patients. Galmozzi E; Aghemo A J Clin Virol; 2014 Apr; 59(4):274-5. PubMed ID: 24495847 [No Abstract] [Full Text] [Related] [Next] [New Search]